Evaluation of PReimplantation embryo Aptitude for DEvelopment (EPRADE)
Abstract
In spring 2020, a group of researchers – investigators of a French program for clinical research in hospitals (PHRC) entitled Comprehensive Chromosomal Testing of Trophectoderm (Te) Biopsies of Blastocysts (Ctteb) to Improve Live Birth Rates After in Vitro Fertilization: A Prospective Randomized Trial, sought the opinion of the Inserm Ethics Committee (CEI) regarding their project. This was on the informal advice of the French Agency of Biomedicine (ABM), despite the Ministry of Health’s Directorate General for Healthcare Provision (DGOS) having already accepted and funded the program and before the French National Agency for the Safety of Medicines and Health Products (ANSM) had approved its performance.
Domains
Ethics| Origin | Files produced by the author(s) |
|---|